Introduction In clinical research, overall survival (OS) has long been the standard endpoint for assessing therapies. Yet OS conflates several competing events that shape patient risk trajectories over extended follow-up. Crude cumulative incidence (CIF) provides a direct, clinically interpretable estimate of the probability that a specific event occurs over time while accounting for competing risks.…